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Although polysaccharides are ubiquitous and the most abundant renewable
bio-components, their studies, covered by the glycochemistry and glycobiology fields,
remain a challenge due to their high molecular diversity and complexity. Polysaccharides
are industrially used in food products; human therapeutics fall into a more recent research
field and pharmaceutical industry is looking for more and more molecules with enhanced
activities. Glycosaminoglycans (GAGs) found in animal tissues play a critical role in
cellular physiological and pathological processes as they bind many cellular components.
Therefore, they present a great potential for the design and preparation of therapeutic
drugs. On the other hand, microorganisms producing exopolysaccharides (EPS) are
renewable resources meeting well the actual industrial demand. In particular, the diversity
of marine microorganisms is still largely unexplored offering great opportunities to
discover high value products such as new molecules and biocatalysts. EPS-producing
bacteria from the marine environment will be reviewed with a focus on marine-derived
EPS from bacteria isolated from deep-sea hydrothermal vents. Information on chemical
and structural features, putative pathways of biosynthesis, novel strategies for chemical
and enzymatic modifications and potentialities in the biomedical field will be provided. An
integrated approach should be used to increase the basic knowledge on these compounds
and their applications; new clean environmentally friendly processes for the production of
carbohydrate bioactive compounds should also be proposed for a sustainable industry.
Keywords: marine-derived polysaccharide, biodiversity, biological activity, structure, modification, GAG-mimetic,
biosynthesis
GLYCOPOLYMERS AND THEIR IMPORTANCE IN
GLYCOBIOLOGY
Polysaccharides are natural macromolecules composed of osidic
monomers and present in all organisms: microorganisms, plants
and animals. Polysaccharides, such as starch, glycogen, and cel-
lulose, are common. However, some other specific classes of
polysaccharides exist based on their origin, chemical structure
and function. Although polysaccharides are ubiquitous, their
chemical structure varies greatly from one to the other. They
have various roles within the cells, from structural involve-
ment to numerous biological activities including interactions.
Therefore, studying the polysaccharide chemical structure and
structure-related activities remains a challenge for glycochemists
and glycobiologists. Polysaccharides can be distinguished by their
osidic composition: homopolysaccharides, which contain a single
type of monosaccharide, and heteropolysaccharides composed of
different osidic residues and usually displaying a regular back-
bone structure with a repeating unit. This repeating unit may
be linear or branched and may contain up to 10 monomers as
well as organic or inorganic substituents such as phosphate, sul-
fate, and lactic, succinic, acetic and pyruvic acids. The chemical
structure including monosaccharide composition and repeat-
ing unit sequence as well as non-carbohydrate substituents is
species-specific (Decho, 1990) and may vary, most of the time,
with production, culture conditions and the physiological state
of the organism. The linkages most commonly found between
monomers are β-1,4 or β-1,3 giving a more rigid backbone vs.
α-1,2 and α-1,6 for more flexible zones. The overall physical
properties of polysaccharides are also influenced by the monosac-
charide composition, the osidic sequence and the network formed
by the single polymer chains (Poli et al., 2010). These poly-
mers are high-molecular weight macromolecules usually above
106 g mol−1.
Most of the polysaccharides used in the industry are extracted
from plants, algae, and animals. A few of them come from
bacteria and have industrial applications in the paper, food,
biotechnological, environmental or health industry (Finore et al.,
2014). The most famous examples of microbial used macro-
molecules have been listed in Table 1 (Kumar et al., 2007;
Freitas et al., 2011). Owing mainly to their rheological prop-
erties, fungal exopolysaccharides (EPS) have also found several
applications in the food, cosmetic and pharmaceutical indus-
tries as well as in oil recovery (Mahapatra and Banerjee, 2013).
Scleroglucan produced by Sclerotium rolfsii, schizophyllan, a
structurally similar molecule produced by Schizophyllum com-
mune and pullulan from Aureobasidium pullulans are the most
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Table 1 | Examples of microbial used macromolecules (adapted from Kumar et al., 2007; Freitas et al., 2011).
Exopolysaccharide Source Main applications
Xanthan Xanthomonas campestris food industry as texturizing agent, petroleum industry, health care
Alginate Pseudomonas aeruginosa, Azotobacter vinelandii food hydrocolloid, wound care, drug encapsulating agent
Dextran Leuconostoc mesenteroides food industry, biomedical as plasma volume expander
biotechnological supports for separation
Cellulose Acetobacter xylinum food industry, biomedical as artificial temporary skin,
biotechnological separations as hollow fiber and membranes
Hyaluronic acid Streptococcus equi, Streptococcus zooepidemicus human health cosmetics
Gellan Sphingomonas paucimobilis food industry, biotechnology (culture medium gelification)
Curdlan Sinorhizobium meliloti, Agrobacterium radiobacter,
Alcaligenes faecalis
food and pharmaceutical industries, bioremediation
Succinoglycan Sinorhizobium meliloti, Alcaligenes faecalis food and pharmaceutical industries, oil recovery
Levans Various food industry (prebiotic)
common fungal polysaccharides of high-added value (Survase
et al., 2007; Mahapatra and Banerjee, 2013). Some of these
polysaccharides are homolog counterparts of plant or animal
macromolecules. Compared to these sources, microorganisms
allow a better controlled production in bioreactors, devoid of no
variation due to physiological state or season encountered for the
highest organisms (Bertagnolli et al., 2014) and an easier extrac-
tion without any drastic or environmentally toxic compounds.
However, downstream processing of bacterial polysaccharides
still represents an important cost intensive step (Kreyenschulte
et al., 2014). Moreover, microorganisms cultivation in fermenters
allows the optimization of the growth and the production yield
either by the study of physiology or by genetic engineering. For
the high-added value pharmaceutical industry, bacterial polysac-
charides can be produced at a viable economic cost. The pro-
duction in controlled conditions is in agreement with the Good
Manufacturing Practices (GMP) such as well-defined medium,
controlled environment without the risk for viral or pathogen
agents. The advantages of a bacterial source over plant, algal
or animal source have made it attractive to obtain macro-
molecules for various industrial purposes and strengthened their
study.
Complex carbohydrates and glycoconjugates have a basic
importance in biological systems and cellular processes, either
physiological or pathological. They play a major role as struc-
tural agents in connective tissues, and they are ubiquitously
present on cell surfaces, mediating the interaction of the cells
with other cells, with the extracellular matrix, with biotic or
abiotic surfaces and with other molecules. But their study
that falls into the field of the glycobiology was greatly hin-
dered by technical issues; no sequencing tool such as that
existing in proteomics or genomics is available to date while
glycopolymers potential chemical diversity is far greater than
proteins and nucleic acids (Turnbull and Field, 2007; Merritt
et al., 2013). While genes and proteins syntheses are based
on a template, polysaccharide biosynthesis is regulated by a
number of physiological and metabolic parameters including
the availability of sugar precursors and the expression level of
enzymes. The number of osidic residues combined with the
anomeric configuration of the linkages and the possibility of
branching result in unique complexity and diversity of carbo-
hydrates molecules. Nonetheless, some advances in analytical
techniques have revealed the vast and diverse chemical struc-
tures of carbohydrates existing in nature (Grice and Wilson,
2010); insights into the structure-function relationship allow
determining their role in diverse cellular processes. Glycobiology
becomes therefore amajor research field allowing the understand-
ing of human diseases and the discovery of novel therapeutic
compounds.
Glycosaminoglycans (GAGs) are glycopolymers found in ani-
mal tissues and composed of uronic acid and neutral or hex-
osamine residues. They are covalently bound to a core protein
and are the major constituent of proteoglycans. Their carbohy-
drate backbone is unique for each cell type. GAGs are essential
for life of animals since they are involved in their development
and organogenesis (De Angelis et al., 2013). Two GAG macro-
molecules are frequently used in various industry fields, namely
hyaluronic acid and heparin.
Hyaluronic acid is a polysaccharide ranging from 500 to 1000
103 g mol−1, with a disaccharidic linear and non-sulfated repeat-
ing unit (Table 2). It is widely used in osteoarthritis treatment
as synovial fluid because of its effect on the cartilage, in oph-
thalmology treatments and surgery because of its visco-elastic
properties, and in wound healing as well as in the cosmetic
industry (moisturizing agent, wrinkle filler).
Heparin is a polyanionic molecule of about 80 103 g mol−1
with 20 to 40% of sulfates exhibiting several biological activi-
ties such as anticoagulant, anti-thrombotic, anti-inflammatory,
antiviral and anticancer (Hirsh et al., 2001). It has been dis-
covered in the early twentieth century and used medically for
over 70 years. The commercially available drug is extracted from
a mucous lining of pig intestines. In parallel, low-molecular
weight (LMW) heparin (6–10 103 g mol−1) has been devel-
oped for use as an anticoagulant to increase benefit-risk ratios
(Hirsh et al., 2001). In 1983, the pentasaccharide unit responsi-
ble for the anti-coagulant and anti-thrombin activity within the
heparin molecule was identified, chemically synthesized (Choay
et al., 1983) and it is now commercialized (Petitou et al., 2002)
(Table 2). Although this molecule presents, as the unfraction-
ated and LMW heparin, some undesirable bleeding side effects
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Table 2 | Repeating unit chemical structures of main glycosaminoglycans and of some marine exopolysaccharides.





from Alteromonas macleodii subsp. fijiensis (Raguenes et al., 1996; Rougeaux et al., 1998)
       4)-β-D-Glcp-(1       4)-α-D-GalpA-(1        4)-α-D-Galp-(1 
           3 
           1 
α-D-GlcpA 
           3 
           1 
β-D-GlcpA 
           4 
           1 
          4,6-Pyr-β-D-Manp
EPS HYD721
from Pseudoalteromonas sp. (Rougeaux et al., 1999a)
       4)-β-D-Manp-(1        4)-β-D-Glcp-(1        4)-α-D-Galp-(1        4)-β-D-Glcp-(1 
           2            3 
   
           1            1 
α-L-Rhap            β-D-Galp
              3 
              1 
              β-D-GlcpA 
              4 
              1 
            [SO3H]         3-β-D-Manp
EPS HE800
from Vibrio diabolicus (Raguenes et al., 1997a; Rougeaux et al., 1999b)
→3)-β-D-GlcpNAc-(1→4)-β-D-GlcpA-(1 →4)-β-D-GlcpA -(1 →4)-α-D-GalpNAc-(1 →
EPS GY785
from Alteromonas infernus (Raguenes et al., 1997b; Roger et al., 2004)
        [SO3Na] 
            ↓
            2 
[→4)-β-Glcp-(1→4)-α-GalpA-(1→4)-α-Galp-(1→] 
            3 
            ↑
            1 
β-Glcp-(1→6)-α-Galp-(1→4)-β-GlcpA-(1→4)-β-GlcpA 
        2              3 
        ↑              ↑
        1              1 
α-Glcp       α-Glcp 
Galp, galactose; GalpA, galacturonic acid; GalpNAc, N-Acetyl-galactosamine; Glcp, glucose; GlcAp or GlcpA, glucuronic acid; GlcpNAc, N-Acetyl-glucosamine;
GlcNp2S6S, N-sulfate-6-O-sulfate-glucosamine; GlcNp2S3S6S, N-sulfate-3,6-di-O-sulfate-glucosamine; GlcNp 2S6S, N-sulfate-6-O-sulfate-D-glucosamine; IdoAp2S,
2-O-sulfate-iduronic acid; Manp, mannose; Pyr, pyruvate group; Rhap, rhamnose; SO3H, sulfate group.
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(Hirsh et al., 2001; Crowther and Warkentin, 2008), it remains
a lead molecule to study the structure-activity relationship. A
heparin contamination crisis arose in the early 2008; some
Chinese heparin preparations caused severe side effects result-
ing in the death of more than 100 patients (Liu et al., 2009).
The impurity was identified as a variant of chondroitin sulfate,
in which sulfate groups exhibited an unusual pattern (Guerrini
et al., 2008). Today, despite the risk of contamination during the
extraction process or by animal pathogenic agents, heparin from
natural sources continues to be widely used clinically. Still new
alternative macromolecules are looked for. In this context, marine
microbial polysaccharides stand for a promising source of macro-
molecules with reduced risk of contamination by mammalian
pathogenic agents. New emerging products of high added-value
from the marine environment, showing structural homology to
heparin such as the presence of sulfate groups, offer the promis-
ing opportunity of novel biologically active compounds (Pomin,
2014a).
Exopolysaccharides (EPS) are glycopolymers that microor-
ganisms secrete in their surrounding environment (Sutherland
et al., 1972). They can be capsular polymers, which are attached
to the cell membrane through the lipopolysaccharides (LPS)
anchored in the membrane or other specific proteins (Decho,
1990). EPS can also be produced as a slime loosely bound
around the cell or dispersed in the environment (Sutherland,
1982). Bacterial polysaccharides are also present within the mem-
brane cell as a major constituent of the LPS and may be
involved in pathogenicity. These glycopolymers have mostly a
protective role and permit resistance under extreme environmen-
tal conditions by participating in the cell membrane integrity,
trapping nutrients, allowing adhesion to surfaces, protecting
from toxic compounds and adverse conditions such as freezing
(Jannasch and Taylor, 1984; Decho, 1990; Finore et al., 2014).
EPS production requires energy from cells representing a car-
bon investment for microorganisms but the benefits to growth
and survival are higher than the production cost (Poli et al.,
2011).
THE MARINE BIOSPHERE AS A SOURCE OF NEW
GLYCOPOLYMERS
Representing more than 70% of our planet, ocean is an
under-explored and under-exploited vast reservoir for biological
organisms and chemical compounds. France owns an expanded
maritime domain as well as oceanographic ships, submarine and
robots allowing to explore the marine biosphere, and especially
deep seas. The marine biosphere is heterogeneous because a
large range of ecosystems exist such as microbial mats, Antarctic
sea ice, hypersaline marine environments, shallow and deep-
sea hydrothermal vents. They are characterized by physical and
chemical parameters such as pressure, temperature, pH, chemi-
cal compounds, usually toxic. Within the deep-sea hydrothermal
vents, large physico-chemical gradients exist; for example, the
temperature varies from 2◦C, the temperature of the surround-
ing sea water to the hot temperature of the hydrothermal plume,
which can reach 350◦C (Baross and Hoffman, 1985). Due to their
microbial diversity, these ecosystems might offer promising new
biomolecules (Deming, 1998).
MARINE ECOSYSTEMSWITH A FOCUS ON DEEP-SEA HYDROTHERMAL
VENTS
Deep-sea hydrothermal vents result from oceanic plate tectonic
and submarine volcanic activities. They appear at the sea ridges
or on subduction back-arc areas, at a depth of 500 to 4000m
(Figure 1). Seawater at high temperature (up to 350◦C) and
charged with metals and other compounds such as hydrogen sul-
fide, hydrogen, ammonia, carbon dioxide flows out of structures
built from precipitates called chimneys. Depending on the com-
position of the fluid, the plume appears with different intensity
of white or black color (white or black smokers) (Burgaud et al.,
2014). Due to volcanic activities of the crust, these ecosystems
are ephemeral (Van Dover et al., 2002). Some other active areas
with a diffuse emission of warm or cold water also exist. Deep-
sea ecosystems also include cold seeps and sediments or microbial
mats (Jannasch and Taylor, 1984). The first hydrothermal vent
was discovered in 1977 in the Galapagos area at a depth of 2600m
(Jannasch and Taylor, 1984), although deep-sea biology started
with the Challenger expedition (1873–1876). The presence of bac-
teria in the open ocean seabed is known since the 1880s from
the Travaillier and Talisman expeditions (1882–1883) (Zobell and
Morita, 1959), when the first microorganisms were found at
5000m deep (Jannasch and Taylor, 1984). In the 1950s, Galathea
expedition collected bacteria-containing sediment samples from
10,000m deep (Zobell and Morita, 1959).
Deep-sea hydrothermal ecosystems, the most productive
ecosystems from the deep ocean, are based on a primary
chimiosynthetic production of organic matter sustaining an
abundant fauna which is mainly composed of endemic species
(Jannasch and Taylor, 1984). These oases of life contrast to the
vast surrounding desertic seafloors. A large variety of microbial
lifestyles has been described in these ecosystems based on the
respiratory type (aerobic-anaerobic), energy and carbon sources.
It is adapted to extreme conditions (barophiles needing high
pressure, acidophiles-alcalophiles, psychrophiles, mesophiles and
extremophiles -growing at temperatures from around 3◦C, the
temperature of seawater, to 105◦C-) (Jannasch and Taylor, 1984).
New microorganisms with very diverse metabolisms have then
been isolated from marine environment especially in deep-
sea habitats (Miroshnichenko and Bonch-Osmolovskaya, 2006).
Halophiles are also encountered in some marine ecosystems.
The high biodiversity potentially offers a large chimiodiversity.
Besides their fundamental interest in basic studies for life origin
understanding, chimiosynthetic metabolisms and mechanisms of
resistance to high temperatures, these microorganisms arise a
great biotechnological interest for the isolation of new enzymes
and biomolecules with new or enhanced activities.
FROMMARINE MICROBIAL BIODIVERSITY TO NEW BIOACTIVE
MOLECULES
Marine biodiversity is not known currently because only a
very small fraction of the microorganisms can be cultivated
(Hugenholtz, 2002; Delong et al., 2006). There are reports on par-
ticular marine environments with high microbial diversity; this
is the case for deep-sea hydrothermal vents in North Atlantic
(Sogin et al., 2006). The next generation high throughput DNA
sequencing (NGS) methodologies can provide a way to estimate
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FIGURE 1 | Global distribution of hydrothermal vent fields (2009) from
http://www.interridge.org/irvents/files/Ventmap_2009.jpg, accessed
2014, September 9. Hydrothermal vent sites from Mid-Ocean Ridge (circles),
Arc volcano (triangles), Back-arc spreading center (squares), other (diamonds)
are shown (active sites are red, unconfirmed are yellow). Ridges are in plain
line, trench are in dashed line. Light blue indicates exclusive economic zones.
the biodiversity and can be useful to drive some cultivation
experiments (Rocha-Martin et al., 2014): when the analysis of
metagenomic data sets reveals incomplete pathway for a given
compound essential for growth, this compound has to be added
as an exogenous source. For example, because SAR11 marine
alpha-proteobacteria clade has been shown to be deficient in
assimilatory sulfate reduction genes, addition of reduced sul-
fur compounds in the cultivation medium was tested and was
revealed necessary for growth (Tripp et al., 2008).
When the biodiversity increases, the chimiodiversity also
increases. Therefore, the chemical study of the marine organ-
isms will most probably result in the discovery of new therapeutic
compounds. In particular, it is well recognized that the chemi-
cal diversity of marine and microbial compounds is the broadest
one (Grabowski et al., 2008). Although microorganisms from
the sea have been studied for several decades, their develop-
ment for biotechnology started only recently (see Imhoff et al.,
2011). Today, only a small fraction of the known species has
been studied for their biochemical metabolites. Marine microor-
ganisms together with sponges, molluscs, algae, echinoderms are
rich source of polysaccharides. Chitin, the second most abundant
polysaccharide after cellulose, is found particularly in the shell
of crustaceans. Alginates, anothermarine-derived polysaccharide,
are extracted from the cell wall of brown algae (Phaecophyta).
Marine-derived polysaccharides naturally bearing sulfate groups
are also industrially relevant: carrageenan (red algae), fucoidans
(brown algae) and fucans (marine invertebrates) (Berteau and
Mulloy, 2003; Kusaykin et al., 2008), ulvan from green sea-
weeds (Chlorophyta) (Lahaye and Robic, 2007). Microorganisms
producing polysaccharides have also been isolated from marine
ecosystems especially from deep-sea hydrothermal vents.
Marine chimiodiversity finds applications in human health
as therapeutic agents for innovative biological activities. New
compounds with new chemical structure can also enable a
better understanding of the cellular processes (pathological or
not): inhibitors of enzymes involved in inflammatory diseases
(manoalide) and phosphorylation processes (okadaic acid), both
extracted from sponge, are available for biochemical research
(Fenical, 1997). Some examples of marine molecules are already
commercialized as analgesic (the peptidic Prialt®), anti-viral
(mainly from corals and sponges), anti-cancer (the alkaloid
Yondelis® by PharmaMar), or as biomaterials (the calcium car-
bonate chemical compound Biocoral® by Biocoral from coral).
Only a few of them are carbohydrates: alginate of plant origin
and chitosan obtained from shrimp extracted chitin have been
successfully integrated within wound dressings (Stop Hemo® by
Brothier Laboratory in France, Nu-Derm® by Johnson & Johnson
in USA) and are also used as encapsulationmatrices (geniaBeads®
by geniaLab in Germany). Most of the marine molecules are
still in research or clinical development, among which four are
from marine microorganisms (Imhoff et al., 2011); this leaves the
marine biotechnology still at a very promising phase; great efforts
are still necessary to get advances in clinical applications.
Bioactive compound prospecting starts with the sampling of
organisms. The choices of methods to prepare extracts and to
screen for the production of bioactive metabolites are critical
steps since they can result in different molecules or even in dif-
ficulties to find the activity. The diversification of sources by the
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exploration of new ecological niches can maintain an effective
process leading to innovative results. Compounds should then be
isolated, structurally characterized especially including the stere-
ochemistry which can be the main issue for its activity. Biological
properties have to be studied in detail, in vitro and subsequently
in vivo before clinical development stages. Alternatively, synthetic
analogs can be studied instead of natural molecules. Chemical
synthesis would offer access to structurally defined oligosaccha-
rides in sufficient purity and quantity to carry out biological
studies. In addition, the synthesis can bring a library of analog
compounds slightly differing in the chemical structure as well
as in the activity. This library would be a useful tool to estab-
lish the structure-activity relationship. Synthetic analogs of the
active pentasaccharide in heparin have been well studied due to
the high value of this drug and its side effects (Avci et al., 2003).
However, synthetic products are sometimes hard to make because
of the complexity of the molecule. This is particularly the case for
polysaccharides for which only small oligosaccharides have been
obtained to date (Boltje et al., 2009). This issue still limits the
progress of glycobiology research and much effort are made to
develop oligosaccharide synthesis methodologies. Recently, Galan
et al. have shown that ionic liquids could be very useful as solvents
and promoters of synthetic reactions (Galan et al., 2013).
MARINE EXOPOLYSACCHARIDES
MICROBIAL POLYSACCHARIDE DIVERSITY
Several EPS-producing marine strains have been studied, which
led to the discovery and isolation of novel macromolecules
(Finore et al., 2014). Marine bacterial polysaccharides have been
the subject of several reviews (Guezennec, 2002; Nazarenko et al.,
2003; Mancuso Nichols et al., 2005b; Laurienzo, 2010; Satpute
et al., 2010; Freitas et al., 2011; Senni et al., 2011; Colliec-Jouault
and Delbarre-Ladrat, 2014; Pomin, 2014b). Most of the marine
derived EPS are bacterial (classical bacteria i.e., mesophilic and
heterotrophic; extremophilic microorganisms i.e., psychrophilic,
thermophilic and halophilic); archaea have also been shown to
produce EPS (Rinker and Kelly, 2000; Nicolaus et al., 2010; Poli
et al., 2011; Finore et al., 2014; Sinquin and Colliec-Jouault,
2014). In the present manuscript, the main focus was put on
the extremophilic prokaryotic marine microorganisms that were
shown to produce EPS, with an emphasis on bacteria isolated
from deep-sea hydrothermal vents.
Mancuso Nichols et al. (2004) described the production of EPS
by the marine strains Pseudoalteromonas CAM025 and CAM036
isolated in Antarctica sea water and sea ice. Some other strains
from Arctic sea ice have been shown to produce EPS with cry-
oprotective effect (Liu et al., 2013).
The halophilic strains Halomonas maura (Arias et al., 2003),
Halomonas ventosae (Martinez-Canovas et al., 2004), Halomonas
alkaliantarctica (Poli et al., 2007), Hahella chejuensis (Poli et al.,
2010) and the archaeal halophilic Haloferax mediterranei (Anton
et al., 1988; Parolis et al., 1996) isolated from hypersaline environ-
ments were also shown to produce EPS; some of them are sulfated
(Poli et al., 2010).
Marine thermophilic anaerobes Sulfolobus, Thermococcus and
Thermotoga were described to produce EPS (Vanfossen et al.,
2008). Thermococcus litoralis produces an EPS which contains
sulfate and phosphorus substituents (Rinker and Kelly, 2000);
the archaea Sulfolobus solfataricus has also been shown to pro-
duce a sulfated polysaccharide (Nicolaus et al., 1993). Geobacillus
sp., Bacillus thermodenitrificans and B. licheniformis thermophilic
strains have been isolated from shallow marine hydrothermal
vents of Vulcano Island (Italy) and the polysaccharide they pro-
duce has been analyzed (Poli et al., 2010).
Several bacteria belonging to gamma-proteobacteria
Alteromonadales or Vibrionales orders and isolated from
the deep-sea polychaete annelids Alvinella pompejana and
A. caudata tissues have been shown to produce different EPS:
HYD1545 (Vincent et al., 1994), HYD1644 (Dubreucq et al.,
1996), HYD721 (Rougeaux et al., 1999a), HYD657 produced by
A. macleodii subsp. fijiensis biovar deepsane (Cambon-Bonavita
et al., 2002) and HE800 produced by Vibrio diabolicus (Raguenes
et al., 1997a; Rougeaux et al., 1999b). This latter polysaccharide
possesses a particular hyaluronic acid-like chemical structure and
contains both hexosamines and uronic acids alternating in the
repeating unit sequence (Table 2) (Sinquin and Colliec-Jouault,
2014).
Another gamma-proteobacterium isolated from a deep-sea
hydrothermal vent shrimp (A. macleodii subsp. fijiensis biovar
medioatlantica) was shown to produce the EPS MS907 (Raguenes
et al., 2003) whereas Alteromonas macleodii subsp. fijiensis pro-
ducing the pyruvated EPS ST716 (Raguenes et al., 1996; Rougeaux
et al., 1998) and Alteromonas infernus producing the sulfated EPS
GY785 were isolated from hydrothermal fluids (Raguenes et al.,
1997b; Roger et al., 2004) (Table 2).
Other Pseudoalteromonas strains produce diverse EPS: SM9913
isolated from deep-sea sediments produces an acetylated EPS
(Qin et al., 2007), SM20310 from the arctic sea ice produces a
complex α-mannan (Liu et al., 2013).
Pseudomonas, Alteromonas, Paracoccus and Vibrio sp. bacteria
producing EPS under laboratory conditions have also been iso-
lated from microbial mats in French Polynesia, another marine
ecosystem considered as extreme. Among them, Paracoccus zeax-
anthinificiens subsp. Payriae and Vibrio sp. RA 29 are described to
produce sulfated polysaccharides and Vibrio sp. MO 245 would
produce a polymer very similar to the Vibrio diabolicus one
(Guézennec et al., 2011).
When known, the chemical and structural diversity of these
fewmolecules confirms the high value of the marine environment
as a source of exciting chimiodiversity.
ALGINATE AND CHITOSAN, TWO MAJOR MARINE POLYSACCHARIDES
Alginate traditionally extracted from brown algae and the most
important polysaccharide from this type of seaweeds is also pro-
duced by soil bacteria Azotobacter and Pseudomonas species as an
exopolysaccharide (Gomez D’ayala et al., 2008). Although they
are not marine bacteria, the polysaccharide is usually refered as
marine derived. A gene cluster for alginate biosynthesis have been
identified in Vibrio sp. QY102 suggesting this polymer would be
involved in the formation of biofilm by Vibrio sp. QY102 (Shi
et al., 2008).
The bacterial alginates are all composed of mannuronic (M)
and guluronic (G) acids arranged in homo-blocks (M or G) and
hetero-blocks (MG) as algal alginates; but that from Pseudomonas
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does not have block G; in addition many of bacterial alginates
are acetylated. G-rich alginates and M-rich alginates have differ-
ent physico-chemical and biological properties (Colliec-Jouault
and Delbarre-Ladrat, 2014). Although their osidic composition
is similar, bacterial alginates vary considerably in their structure
depending on the producing strain and in the case of alginate
produced by seaweeds, on seasonal and environment variations
(Gomez D’ayala et al., 2008; Bertagnolli et al., 2014). Industrial
production of alginate reaches 30,000 tons annually and it is used
as a viscosifier, stabilizer and gelling agent (Hay et al., 2013).
Chitin and chitosan, its partially N-deacetylated derivative, are
the most abundant marine polysaccharides; they have great inter-
est for biotechnological applications. They are mainly extracted
from shellfish waste. To date no bacterium has been described
to produce either chitin or chitosan. Nonetheless, some bacteria
have been shown to produce PNAG, poly-N-acetyl-glucosamine,
a β-1,6-linked N-acetyl-D-glucosamine homopolymer, struc-
turally close to chitin, β-1,4-linked N-acetyl-D-glucosamine
homopolymer (Whitney and Howell, 2013; Ye et al., 2014).
PRODUCTION AND PHYSIOLOGICAL CONDITIONS INFLUENCE
Production of polysaccharides by bacteria is a physiological pro-
cess that takes place under a diversity of environmental conditions
(Kumar et al., 2007), usually in response to a stress including
the adaptation to extreme environment (Lapaglia and Hartzell,
1997). In the marine environment, bacteria are usually attached
to biotic or abiotic surfaces and are embedded in a slime,
an exopolymeric matrix composed of proteins, polysaccharides,
DNA and small organic molecules; they form biofilms as a protec-
tive response to a stress (Lapaglia and Hartzell, 1997; Guezennec,
2002; Liu et al., 2013). Therefore, it is important to identify any
relationship between the biosynthesis of EPS and biofilm forma-
tion regulation in order to better control the production process
(Rehm, 2010). Limitations in the availability of nutrients such
as nitrogen, phosphorous, sulfur, potassium (Kumar et al., 2007;
Sabra and Hassan, 2008), as well as temperature, osmotic or pH
shifts (Gorret et al., 2001; Kumar et al., 2007) are stressing factors
enhancing EPS production. Moreover, a suitable carbon source to
be added to the production or growth medium is also a main fac-
tor for the yield and features of the produced molecule (Donot
et al., 2012). Its excess, in fact, is concomitant with another com-
ponent limitation such as nitrogen (Freitas et al., 2011). In some
cases, the osidic composition of the molecule can change with the
carbon substrate (Grobben et al., 1996; Poli et al., 2007; Freitas
et al., 2011).
Production yield of marine EPS is usually around 1 g L−1
(Decho, 1990). Industrial development is conceivable for a pro-
duction yield around 10 g L−1. Production costs are driven by the
yield of polysaccharide, the amount and cost of carbon source,
and by the downstream processes needed formolecule separation.
Therefore, studies on production optimization are needed even if
some bacterial strains are naturally able to produce EPS at a high
yield (e.g., 50 g L−1 or over) such as Agrobacterium sp. (curdlan),
Xanthomonas campestris (xanthan), Zymomonas mobilis (levan),
Alcaligenes faecalis (curdlan), Bacillus sp. (levan) (Donot et al.,
2012). Factors such as medium composition and fermentation
conditions i.e., temperature, pH and aeration stand for the main
studied variables to optimize the fermentation process (Mancuso
Nichols et al., 2005a; Sabra and Hassan, 2008; Finore et al., 2014).
The nutritional conditions can also affect the molecular weight as
well as the osidic composition of the EPS in some cases (Mancuso
Nichols et al., 2005a; Poli et al., 2009; Donot et al., 2012; Finore
et al., 2014). A novel Alteromonas macleodii strain has been shown
to produce 23.4 g L−1 exopolysaccharide when grown on 15% lac-
tose which is the highest yield obtained for marine EPS (Mehta
et al., 2014).
Fermentation is usually performed in batch or fed-batch. Heat
transfer and oxygen supply limitations are however encoun-
tered when EPS are highly viscous (Kreyenschulte et al., 2014).
Depending on the producing bacterium, the EPS may be
produced during the growth (cellulose, gellan or alginate by
Azotobacter vinelandii), when the growth has ended (curdlan by
Alcaligenes faecalis), during the stationary phase (Raguenes et al.,
1996) or both (xanthan by X. campestris) (Decho, 1990; Freitas
et al., 2011). The marine EPS HYD1644 is produced only after
the initial exponential growth phase (Samain et al., 1997). In
Pseudomonas sp., an EPS is produced during the exponential
phase and another one with a different chemical structure is
produced during the stationary phase (Christensen et al., 1985).
Some reports emphasize the benefit of a growth-production
uncoupling by using a bacteriostatic to stop the growth together
with the addition of the carbonated substrate and/or shift in
temperature or pH (Looijesteijn and Hugenholtz, 1999).
DOWNSTREAM PROCESS FOR EPS RECOVERY
After fermentation, the downtream process for the recovery of
EPS is an important step for the production costs and commercial
value of the molecule. Process steps will depend on the molecule,
on other undesired molecules produced, but also on the level of
purity required.
Downstream process, consisting of the removal of insol-
uble particles, isolation of the product and further purifica-
tion, is based on classical steps of extraction and purification.
Each method has its advantages and disadvantages (Sinquin
and Colliec-Jouault, 2014). Various molecules are usually asso-
ciated with polysaccharides that act as sponges for some proteins,
amino acids, DNA, RNA, salts, metals, fatty acids either dissolved
in seawater based medium or released after cell lysis (Decho,
1990; Freitas et al., 2011; Donot et al., 2012). The presence of
degrading enzymes or of a second biopolymer must also be
taken into account for a good purification process (Kreyenschulte
et al., 2014). Therefore some isolation procedures may be better
adapted than others as reviewed by Donot et al. (2012).
Centrifugation or filtration step is usually used to remove
cells from the culture broth without lysis and EPS isolation
(Kreyenschulte et al., 2014). Culture broth is sometimes subjected
to heating at the end of the fermentation to kill the bacteria
and denature potential polymer-degrading enzymes (Freitas et al.,
2011) but this may result in some cell lysis and release of com-
pounds in the soluble medium. The deactivation of the cells is
alternatively carried out by chemical, enzymatic or mechanical
treatment (Kreyenschulte et al., 2014).
Separation and purification of the biopolymer can be obtained
by precipitation with the addition of alcohol or by complexing
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metal ions (Kreyenschulte et al., 2014). However, ethanol pre-
cipitation may trap and co-precipitate proteins and ions (Kumar
et al., 2007) and needs a large amount of alcohol. Filtration or
ultrafiltration is recognized as a good method to separate high
molecular weight from other small adsorbed compounds and has
been used since a long time (Wilkie et al., 1957; Kreyenschulte
et al., 2014). Some additional extractions to remove contami-
nating compounds may be appropriate such as new precipita-
tion, chemical extraction or enzymatic treatment but they may
decrease the recovery yield (Decho, 1990; Freitas et al., 2011).
These separation steps can in turn be hindered when polysaccha-
ride is highly viscous; higher temperature or dilution in watermay
facilitate the process however increasing the costs (Freitas et al.,
2011). The choice of the whole procedure has to be adapted to
polymer characteristics as well as to the desired recovery yield,
purity and integrity degrees. After isolation, the polysaccharide is
freeze dried for a better conservation. Polysaccharides are highly
hydrophilic due to hydroxyl groups, especially when they are
polyanionic (carboxyl groups), a widespread feature in marine
environment, or when they bear sulfate groups; therefore they
always conserve a content of water (De Angelis et al., 2013).
PUTATIVE PATHWAYS OF BIOSYNTHESIS
The genetics of the EPS biosynthesis begins to be better under-
stood; however, information appears disparate because it depends
on the concerned microorganism and the polysaccharide that it
produces.
However, depending on the type of polysaccharide, some gen-
eral mechanisms can be described (Rehm, 2010). An extracellular
glycosyltransferase (GT) is responsible for the biosynthesis out-
side the cell of homopolysaccharides such as dextran, levan,
mutan. This particular GT (usually sucrase) cleaves a disaccharide
substrate (usually sucrose) and transfers one of the two obtained
monomers to the polymer chain (Rehm, 2010). The occurrence
of these enzymes is however limited in marine microorganisms
(Decho, 1990).
Except for mechanisms involving sucrase, the biosynthesis
starts with the production of nucleotide sugars which will be
linked in the repeating unit of the molecule. They are biosynthe-
sized within the central cellular metabolism with usually known
enzymes (Rehm, 2010). The repeating unit is then synthesized
by appropriate GTs (Whitfield, 2006; Rehm, 2010). After comple-
tion, the repeating unit is exported outside the cell and polymer-
ized on the growing EPS chain. Based on biosynthesis and export
mechanisms, three pathways have been described.
Some simple heteropolysaccharides (two different residue
types maximum such as hyaluronic acid) as well as some
homopolysaccharides (cellulose, chitin) are synthesized by a syn-
thase enzyme which polymerizes nucleotide sugars while export-
ing the growing polymer chain outside the cell (Weigel and De
Angelis, 2007; Rehm, 2010). The second pathway relies on the
ABC transporter for exportation of the entire polysaccharide syn-
thesized on a lipid carrier (Whitney and Howell, 2013). The third
mechanism depends on Wzx-Wzy proteins.
The Wzx-Wzy dependent mechanism has been widely stud-
ied in Gram negative bacteria especially for heteropolysaccharide
production. Biosynthesis is catalyzed by a membrane-spanning
multiprotein complex (Rehm, 2010). A particular GT involved
in the initiation step, the phosphoglycosyltransferase (pGT),
anchors the first osidic residue to amembrane lipid carrier (unde-
caprenyl phosphate) through a phosphoryl bond (De Vuyst et al.,
2001; Whitfield, 2006). After completion of the repeating unit by
successive GTs, it is exported outside the cell across the inner
membrane by Wzx and subsequently polymerized by the Wzy
protein (Whitfield, 2006). The lipid carrier anchor is also recog-
nized for the translocation of the repeating unit across the inner
membrane (Rehm, 2010). The final translocation across the outer
membrane involves a member of the outer membrane polysac-
charide export protein family such as Wza (Reid and Whitfield,
2005). Heteropolysaccharides from the Gram-positive lactic acid
bacteria are synthesized by a very similar mechanism (De Vuyst
et al., 2001).
Besides these four types of biosynthesis mechanisms (extra-
cellular, synthase-, Wzx-Wzy- and ABC-transporter), some other
gene clusters showing a peculiar mechanism have been described.
In general, the overall regulation of the biosynthesis is not
completely understood as well.
Sphingans are heteropolysaccharides produced by
Sphingomonas bacteria, some of whom are of marine origin
(Cavicchioli et al., 1999). These polymers are characterized
by a tetrasaccharide backbone structure containing rhamnose
or mannose (1), glucose (2) and glucuronic acid (1). Gellan,
diutan, welan, rhamsan, and sphingan S-88 are examples of
them differing by their side chain and substituents (Harding
et al., 2004; Freitas et al., 2011). The biosynthesis of sphingans
has been recently reviewed by Schmid et al. (2014). The orga-
nization of genes required for diutan, welan, gellan, S-88 and
S-7 biosynthesis shows similarities; genes for polysaccharide
and protein secretion, as well as an operon for the synthesis
of dTDP-rhamnose are conserved suggesting a well-conserved
mechanism for polysaccharide biosynthesis and secretion
(Yamazaki et al., 1996; Harding et al., 2004; Coleman et al., 2008).
The mechanism starts by the transfer of glucose-1-phosphate
on the isoprenylphosphate lipid. Successive GTs transfer the
other sugar nucleotide to the repeating unit similarly to the first
steps of Wzx-Wzy dependent mechanisms (Coleman et al., 2008;
Schmid et al., 2014). A putative gene for lyase is only present
in diutan gene cluster. Comparison of the three gene clusters
allowed also the identification of a candidate gene encoding the
protein responsible for the addition of rhamnosyl side chain.
Alginate biosynthesis genes in Azotobacter and Pseudomonas
bacteria are similar (Rehm and Valla, 1997), the 12-core genes are
clustered in a single operon. Only slight differences exist especially
in the regulation (Donot et al., 2012; Hay et al., 2013). Alginate
is synthesized as polymannuronnic acid in an undecaprenol-
independent manner (Remminghorst and Rehm, 2006) and is
O-acetylated in the periplasm. The gene cluster includes genes
for the precursor synthesis (GDP-mannuronic acid), the poly-
merization, the translocation across the inner membrane and
the periplasm where alginate encounters some modifications
(O-acetylation and C5-epimerization of mannuronic acid to
guluronic acid), and the alginate secretion (Remminghorst and
Rehm, 2006; Hay et al., 2013). In the case of alginate biosyn-
thesis by Azotobacter vinelandii and Pseudomonas fluorescens, the
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molecular mechanisms of polymerization and export are not fully
understood (Rehm, 2010), but are based on a synthase-dependent
mechanism (Whitney and Howell, 2013).
The groups of genes necessary for the biosynthesis of an het-
eropolysaccharide are typically clustered at one genetic locus of
12–25 kb including genes for the synthesis of the repeating unit
(GTs), genes for export, polymerization and regulation (Laws
et al., 2001). These clusters are also well known in lactic acid
bacteria (LAB) such as Streptococcus spp. (Wu et al., 2014) and
Bifidobacterium spp. (Hidalgo-Cantabrana et al., 2014); in LAB,
EPS biosynthesis gene clusters are often located on plasmids
(Kumar et al., 2007; Donot et al., 2012). Furthermore, Escherichia
coli polysaccharide biosynthesis pathways have become a refer-
ence model in these studies (Whitfield, 1995, 2006; Willis and
Whitfield, 2013).
The activated precursors are also needed for the synthesis of
some other cellular components such as peptidoglycan for mem-
branes (Merritt et al., 2013). Therefore, it is of high importance to
understand the fluxes of carbon, nitrogen and energy leading both
to cells and bioactive molecules or, at least, to modulate them by
physiological optimizations or genetic engineering (Rehm, 2010).
It is highly probable, due to their respective role, that cell wall
biosynthesis has priority, LPS and finally EPS synthesis (Decho,
1990).
With the post-genomic era, more clusters involved in biosyn-
thesis of polysaccharides are described together with some regula-
tions issues. An understanding of how the high-molecular weight
polymers are biosynthesized may lead to better efficiencies in EPS
production at an industrial level and a better comprehension of
how varies the composition upon production conditions. New
strategies like genetic engineering of producing microorganisms
are being developed to enhance polysaccharide yield and allow an
economically effective production (Ates et al., 2011; Finore et al.,
2014). On the other hand, the prediction of metabolic network
can allow the identification of key factors for an enhanced pro-
duction: from the genome sequence, mannitol was identified as a
stimulator for levan biosynthesis by Chromohalobacter salexigens
(Ates et al., 2011), experimental evidence was achieved later in
another halophilic bacterium Halomonas smyrnensis (Ates et al.,
2013). Metabolic engineering approaches can complement ongo-
ing efforts on fermentation process engineering with the aim to
optimize EPS production (Merritt et al., 2013). In this strategy,
research on K5 EPS biosynthesis is a good example as reviewed
by Wang et al. (2011). Fermentation process has been optimized
for a better yield and productivity of heparosan. Conversion of
UDP-glucose to UDP-glucuronic acid by the UDP-glucose dehy-
drogenase together with the UDP-N-Acetyl-glucosamine pathway
have been identified as limiting steps to keep balanced supply of
nucleotide sugars both for heparosan biosynthesis and cell wall
synthesis. Genetic engineering targeting these metabolic reactions
has revealed the necessity of a balanced over-expression of KfiA
and KfiC GTs. Since a part of the K5 polysaccharide remains
linked to the cell membrane, the gene of the K5 lyase capable of
breaking this linkage has been genetically modified to increase the
amount of K5 released in the supernatant (Wang et al., 2011). K5
lyase gene can also be genetically engineered to control the chain
length (Wang et al., 2011).
NOVEL STRATEGIES FOR CHEMICAL AND ENZYMATIC MODIFICATIONS
Overall, physical and bioactive features of polysaccharides are
based on molecular chemical structure: the osidic sequence and
linkages in the repeating unit, but also the substituents, influ-
ence the conformation and geometry of polysaccharide chains
as well as polysaccharide-polysaccharide and polysaccharide-
protein interactions (Powell et al., 2004; Pomin, 2009). The chem-
ical structure determines the physical properties such as solubility
in water or interactions with ions (Geddie and Sutherland, 1993;
Kumar et al., 2007). For examples, the acetyl content in chitosan
sulfate influences the inhibition of propyl endopeptidase which
is involved in progressive memory deficits and cognitive dysfunc-
tions (Je et al., 2005). The sulfate groups in heparin participate in
the molecular conformation and influence the binding with cal-
cium cations (Chevalier et al., 2004). They also have a great effect
on the anticoagulant activity (Franz and Alban, 1995; Garg et al.,
2002; Huang et al., 2003; Liu and Pedersen, 2007). The antiprolif-
erative activity of the heparin molecule depends on the molecular
size but not on 3-O-sulfo group (Garg et al., 2002) and requires
both N-acetylation and N-sulfation (Longas et al., 2003). As
found for heparin structure-function relationships, the amount
of sulfate groups, their distribution pattern and the molecular
weight are of great importance for GAG-like activities. Therefore,
marine polysaccharides may be structurally modified e.g., depoly-
merized and (over-)sulfated to render them active or to enhance
already existing activities (Chopin et al., 2014).
Chemical modifications are widely used for this purpose
(Gomez D’ayala et al., 2008; Laurienzo, 2010; Senni et al., 2011):
acid hydrolysis (Colliec et al., 1994), radical depolymerization
(Nardella et al., 1996), N-deacetylation (Zou et al., 1998), sul-
fation (Nishino and Nagumo, 1992; Guezennec et al., 1998).
However, several drawbacks such as lack of control and regioselec-
tivity, use of organic solvents, non-homogeneous conditions are
identified (Al-Horani and Desai, 2010). More recently, ionic liq-
uids have been used for cellulose sulfation in homogeneousmedia
(El Seoud et al., 2007; Gericke et al., 2011). Only few reports
deal with chemical modifications on marine EPS (Gomez D’ayala
et al., 2008). Low-molecular weight oversulfated derivatives of
the EPS GY785 from the deep-sea bacterium A. infernus and of
the EPS HE800 from V. diabolicus have been obtained by depoly-
merization by acid hydrolysis or free-radical reaction followed by
sulfation with sulfur trioxide pyridine complex (Colliec-Jouault
et al., 2001; Senni et al., 2011). The low-molecular weight and
oversulfated derivatives thus obtained exhibit biological activi-
ties similar to heparin and other GAGs (Ruiz Velasco et al., 2011;
Senni et al., 2011, 2013; Sinquin and Colliec-Jouault, 2014).
Target compound yield by chemical process is low after purifi-
cation steps and sulfation lacks specificity giving undesirable
by-products or uncontrolled final product chemical structure
resulting in non-homogeneous products (Chopin et al., 2014).
Enzymes, because of their specificity, may allow a better control of
the reactions catalyzed. Moreover, enzymatic reactions are more
friendly to the environment without the need of solvent or toxic
chemicals.
To date, several strategies combining chemical and enzymatic
methods for the synthesis of GAGs have been developed (De
Angelis et al., 2013). After sugar backbone isolation or synthesis,
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modifications, usually using enzymes cloned from vertebrates up
to now, are performed in vitro.
Escherichia coliK5 polysaccharide has the same chemical struc-
ture as the biosynthetic precursor of heparin (heparosan); it has
beenmodified by combinations of chemical and enzymatic meth-
ods and converted to “biotechnological heparin” (Kusche et al.,
1991; Naggi et al., 2001; Urbinati et al., 2004; Lindahl et al.,
2005). N-deacetylation and N-sulfation were achieved by chemi-
cal reactions, and C5-epimerization of glucuronic acid (GlcA) to
iduronic acid (IdoA) was carried out using the enzyme epimerase.
The sulfation reaction was not regioselective enough and was
improved in 2005 to yield the desired 2-O-sulfated IdoA (Lindahl
et al., 2005); at that time, even if the chemical structure of this
neoheparin was still not identical to the heparin AT-binding
sequence, biological properties were similar to those of hep-
arin. Other similar chemoenzymatic processes have been patented
(Zopetti et al., 2006).
The sulfation step is crucial in these biotechnological pro-
cesses. Although chemical sulfation is not specific enough, only
a few biotechnological processes involve sulfotransferases (STs).
In particular, a selectivity toward the sulfation state of the sub-
strate exists (De Angelis et al., 2013). Enzymatic sulfations are
however limited by the need of the expensive sulfate donor 3′-
phosphoadenosine 5′-phosphosulfate (PAPS). Chondroitin sul-
fate E has been synthesized from chondroitin sulfate A using a
sulfotransferase extracted from squid cartilage (Habuchi et al.,
2002). In this study, dermatan sulfate has also been oversulfated
with the same enzyme. Enzymatic sulfation has been used to
prepare heparan sulfate from chemically desulfated N-sulfated
heparin (Chen et al., 2005). Using heparan sulfotransferases (2-
OST, 6-OST, 3-OST) expressed in E. coli and immobilized, as
well as PAPS regeneration system, the polysaccharide substrate
was subjected to different enzymatic modifications resulting in
heparan sulfates with distinct biological activities.
However, although promising, chemoenzymatic methods still
need more research efforts to allow the synthesis of GAG-like
macromolecules. These multiple step processes are expensive due
to the PAPS cost and the production capacity remains limited
for a demand in heparin of about 100 tons per year (De Angelis,
2012).
Chitin and chitosan have been extensively studied for their
biotechnological applications and have been subjected to a large
range of modifications to modulate their biological properties,
hence determining their applications (Gomez D’ayala et al.,
2008). Removal of acetyl groups (deacetylation) from chitin is
the first of the studied modifications among others including
carboxymethylation, sulfation, acylation (Gomez D’ayala et al.,
2008).
A new alternative to chemical and enzymatic modifications
to obtain targeted polysaccharide chemical structure could also
be the genetic engineering. This will be feasible if more EPS
structures are known together with biosynthetic genetic clus-
ters as well as relationship between structure and bioactivity.
EPS biosynthesis pathway reconstruction is feasible with genome
sequence and functional annotation and it can be engineered to
obtain tailor-made polymers (Schmid et al., 2014). If biosynthe-
sis mechanisms are known, the over-expression or inhibition of
targeted genes may lead to enhanced EPS production. It may
also allow a better insight into protein function as well as the
biosynthesis of tailored molecules with desired features in terms
of molecular weight, osidic structure and functional substituents.
The activity of GT GumK involved into the biosynthesis of xan-
than has been modified by protein engineering; this resulted in a
variation in the xanthan production yield highlighting the possi-
bility to obtain tailor-made xanthanmolecules by GT engineering
(Barreras et al., 2008). Attempts to determine genes involved
in the molecular weight control of diutan in Sphingomonas sp.
were not successful (Coleman et al., 2008), suggesting that the
chain length regulation is very complex whatever the biosyn-
thesis mechanism considered (Whitfield, 2010). In Pseudomonas
aeruginosa, the GDP-mannose dehydrogenase has been identified
by over-expression studies as a key regulator protein in alginate
biosynthesis (Tatnell et al., 1994).
On the other hand, genomic data would also allow the identifi-
cation of new enzymatic tools to modify glycopolymers. Enzymes
would become promising biotechnological tools for in vitro syn-
thesis or in vivo biosynthesis engineering. Themarine biodiversity
has already shown a great potential in providing new biocatalysts
(Trincone, 2010). Depolymerising enzymes can be used in in vitro
depolymerization process but also as tools to study the chemi-
cal structure. Carbohydrate sulfotransferases and other enzymes
grafting substituents such as acetate, as well as enzymes catalyzing
their removal, may be used in vitro for binding or for elimina-
tion of substituents which are of great importance for the final
bioactivity of the molecule. GTs specificity are difficult to char-
acterize especially when they belong to the polyspecific family 4
or 2 (http://www.cazy.org/). Identifying both the polysaccharide
chemical structure and the genetic cluster for the biosynthe-
sis would allow the knowledge of the GT enzymatic function
in the biosynthetic pathway by genetic knockout. It would also
provide useful directions to determine enzymatic specificity and
characterize the enzymes.
Recombinant production can be envisioned when polysac-
charide biosynthesis cluster is known: it consists in the cloning
of the entire biosynthesis cluster in an appropriate heterol-
ogous host. This is a new strategy developed together with
the expansion of synthetic biology (Winter and Tang, 2012;
Cameron et al., 2014; Church et al., 2014). Up to now, only
less complex polymers have been studied in recombinant pro-
duction such as hyaluronic acid (Chien and Lee, 2007; Cimini
et al., 2011), chondroitin (Ninomiya et al., 2002) and heparosan
(Roman et al., 2003).
CONCLUDING REMARKS
Natural bioactive molecules attract many interests in the search
for new therapeutic drugs. Marine environment shields a high
diversity of natural products and can be indeed a treasure chest
for industrial and pharmaceutical purposes. Due to their func-
tions in survival and competitiveness of marine bacteria in low
nutrients and adverse environments, the EPS are ubiquitous in
the marine environment.
In addition to various marine origins (animals, seaweeds,
invertebrates), microorganisms provide glycopolymers with orig-
inal chemical structure and promising biological activities. The
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marine biotechnology has not yet reached an economically
significant field but is a promising field for sustaining convenient
macromolecules.
It is also assumed that new isolated bioactive molecules are
also thematter for bioinspired newmolecules obtained by synthe-
sis. For this purpose, both the discovery of new natural bioactive
molecules and their structural characterization are still of con-
siderable importance to obtain well characterized molecules with
truly identified mechanism of action. Basic and applied research
efforts in this field require a close collaboration between biologists
and chemists and expertise in marine microbiology, biochem-
istry, biology, chemistry and computational sciences to fulfill
screenings, structural characterization, bioactivity studies and
biosynthesis understanding and metabolic engineering issues.
With the synthetic biology approach, a new era is available for
the polysaccharide production field by simple ways.
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